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Levels and Patterns of Self-Reported and Objectively-Measured 
Free-Living Physical Activity Among Prostate Cancer Survivors: 
A Prospective Cohort Study
Lee Smith, PhD1; Jung Ae Lee, PhD2,3; Junbae Mun, PhD4; Ratna Pakpahan, MBBS, MH2; Kellie R. Imm, BA2,5;  
Sonya Izadi, BA2; Adam S. Kibel, MD6; Graham A. Colditz, MD, DrPH2; Robert L. Grubb III, MD7,8; Kathleen Y. Wolin, ScD9; 
Siobhan Sutcliffe, PhD2; and Lin Yang, PhD2,10
BACKGROUND: No prior study has measured or compared self-reported and objectively measured physical activity trajectories in 
prostate cancer survivors before and after treatment. METHODS: Clinically localized prostate cancer patients treated with radical 
prostatectomy were recruited between 2011 and 2014. Of the 350 participants enrolled at the main site, 310 provided self-reported 
physical activity at baseline before radical prostatectomy, and 5 weeks, 6 months, and 12 months after radical prostatectomy. A 
subset of participants (n = 81) provided objectively measured physical activity at all study time points by wearing an accelerom-
eter for 7 days each. Changes in activity over time were compared using Friedman’s test. Agreement between self-reported and 
objective measures was evaluated using Spearman’s rank correlation coefficient. RESULTS: Self-reported moderate-to-vigorous 
physical activity was high at baseline (median, 32.1 min/day), followed by a decline at 5 weeks (median, 15.0 min/day) and a recov-
ery at 6 and 12 months (median, 32.1-47.1 min/day). In contrast, objectively measured moderate-to-vigorous physical activity was 
low at all 4 time points (median, 0.0-5.2 min/day), with no overall change across study assessments (global P = .29). Self-reported 
moderate-to-vigorous physical activity tended to be more closely related to objectively measured light-intensity physical activity (ρ 
= 0.29-0.42) than to objectively measured moderate-to-vigorous physical activity (ρ = 0.07-0.27, P = .009-.32). CONCLUSIONS: In 
our population of prostate cancer survivors with critically low moderate-to-vigorous physical activity levels, self-reported measures 
greatly overestimated moderate-to-vigorous physical activity and may have been more reflective of light-intensity physical activity. 
Because cancer survivor guidelines are derived from self-reported data, our findings may imply that intensities of physical activity 
below moderate, such as light intensity, still have health benefits. Cancer 2019;125:798-806. © 2018 The Authors. Cancer published 
by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creat ive 
Commo ns Attri butio n-NonCo mmerc ial-NoDerivs License, which permits use and distribution in any medium, provided the original 
work is properly cited, the use is non-commercial and no modifications or adaptations are made. 
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INTRODUCTION
In cancer survivors (defined as anyone diagnosed with cancer),1 regular and sustained participation in physical activity 
is associated with reduced cancer recurrence and improved survival, as well as a range of physical and psychological 
outcomes and health-related quality of life.1-5 The majority of knowledge about the benefits of physical activity among 
cancer survivors has been derived from self-reported,1-4 as opposed to objectively measured,6-8 physical activity data. 
Although self-reported measures are useful for ranking participants by their relative physical activity levels and for 
monitoring changes in activity over time, they are less useful for estimating absolute levels of free-living physical ac-
tivity. Self-reported measures have lesser accuracy for measuring light-intensity physical activity (eg, routine domestic 
tasks) than objective measures, require highly complex cognitive processing, and are susceptible to social desirability 
and recall biases.9 Moreover, many of these factors may be more pronounced in cancer survivors. For example, cancer 
survivors in general may have greater difficulty recalling physical activity because of cancer- or therapy-related cognitive 
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impairments, such as lack of concentration and short-
term memory loss.10,11 However, no study to date has 
compared self-reported with objectively measured phys-
ical activity in cancer survivors to inform the degree of 
discrepancy between these 2 measures.
A key challenge for the development of cancer sur-
vivor physical activity guidelines is to identify the appro-
priate timing of physical activity engagement, given that 
little is known about cancer survivors’ physical activity 
levels before and after therapy. Although a few studies 
have documented declined physical activity levels follow-
ing a cancer diagnosis using self-reported measures,12-15 
these may not reflect actual levels for the aforementioned 
reasons. Moreover, discrepancies between self-reported 
and objective measures may be exacerbated further by 
the influence of therapy on survivors’ activity levels and 
cognitive function. A limited number of studies have col-
lected repeated measures of objective physical activity in 
cancer survivors to inform actual trajectories, but most of 
these studies were small in size (eg, <30 participants16-20) 
or lacked pretreatment data.21,22 Therefore, additional 
studies of objectively measured physical activity trajecto-
ries in cancer survivors are needed to document their ac-
tual physical activity levels throughout their survivorship.
To begin to address these gaps, we investigated and 
compared levels and patterns of self-reported and objec-
tively measured physical activity in a large cohort of men 
undergoing radical prostatectomy for clinically localized 
prostate cancer, the most commonly diagnosed cancer in 
men in the United States.
PATIENTS AND METHODS
Study Population and Design
The Prostatectomy, Incontinence, and Erectile Function 
study was a multicenter longitudinal clinical cohort 
study based at 2 sites in the United States: Washington 
University School of Medicine and Brigham & Women’s 
Hospital. Men scheduled to undergo radical prostatec-
tomy for clinically localized prostate cancer were re-
cruited between September 2011 and January 2014. 
All men undergoing prostatectomy were eligible except 
for those who had previously undergone treatment for 
prostate cancer, radiation treatment to the pelvic region 
(including bladder, rectum, or prostate), major pelvic 
surgery, or placement of a penile implant or artificial 
urinary sphincter. We also excluded men with known 
urethral stricture or colostomy, men who were unable to 
urinate and required chronic urinary catheterization, and 
men who did not speak English. In total, we enrolled 
350 men at Washington University and 76 at Brigham & 
Women’s Hospital.
Before their surgery, participants were asked to com-
plete a questionnaire that included questions on recent 
physical activity, weight history, insurance status, urinary 
and sexual function and bother, medications that can 
impact urinary and sexual function, and a range of so-
cio-demographic characteristics. Participants completed a 
similar questionnaire 5 weeks, 6 months, and 12 months 
after surgery. Comorbidity data and clinical prostate can-
cer information (including stage, Gleason score, and pre-
treatment prostate-specific antigen levels) were abstracted 
from participants’ medical records. Baseline height and 
weight were measured at the preoperative clinic visit 
by nursing staff. Participants enrolled at Washington 
University were also given the option of wearing an ac-
tivity monitor. Those who agreed were asked to wear an 
Actigraph GT3X+ accelerometer for 7 days at each of the 
study time points: baseline before radical prostatectomy 
and 5 weeks, 6 months, and 12 months after radical pros-
tatectomy. Participants enrolled at Brigham & Women’s 
Hospital were not given the option of wearing an ac-
celerometer and were thus not included in the present 
analyses. The Prostatectomy, Incontinence, and Erectile 
Function Study was approved by the institutional review 
boards at Washington University School of Medicine and 
Brigham & Women’s Hospital. All participants provided 
informed consent.
Self-Reported Physical Activity
Recent physical activity was assessed using the 
Community Healthy Activities Model Program for 
Seniors (CHAMPS) physical activity questionnaire for 
older adults. This instrument measures physical activities 
that participants may have engaged in “in a typical week 
in the past four weeks”. The CHAMPS instrument has 
been found to have good reproducibility in older men 
(Pearson’s r = 0.58-0.67)23 and has been validated in ra-
cial/ethnic minorities.24,25 It was administered at all 4 
study time points. We used this questionnaire to summa-
rize the total daily self-reported amount of moderate-to-
vigorous physical activity in minutes for each participant 
at each study assessment.
Objectively Measured Physical Activity
A subsample of participants agreed to wear a waist-worn 
accelerometer (Actigraph GT3X+, 1 second epochs) for 
7 consecutive days to measure free-living physical activ-
ity objectively. The Actigraph GT3X+ is a small, light-
weight, extensively validated device that provides detailed 
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information about the intensity, frequency, and duration 
of physical activity.22,26-28 The epoch length was set at 
1 second, and the Actigraph recorded count data for 
physical activity in the form of counts per minute (cpm). 
Nonwearing time was defined as 60 minutes of consecu-
tive zero counts with allowance for 1 or 2 minutes with 
<100 cpm. A recording of at least 10 hours of data (about 
two thirds of waking hours per day) was defined as a 
valid day, and 3 or more valid days measured at any time 
during the 7-day wearing period were required for the 
analysis.22
Actigraph data were processed using ActiLife soft-
ware based on the Freedson equation29 to derive 1) total 
wearing time, 2) “raw” minutes spent in moderate-to-vig-
orous physical activity bouts (>1951 cpm) of at least 10 
minutes, and 3) sedentary behavior (<100 cpm). Raw 
minutes spent in light-intensity physical activity were 
calculated by subtracting raw minutes spent in moder-
ate-to-vigorous physical activity bouts of 1 minute and 
sedentary behavior from the total wearing time, namely 
100 to 1951 cpm. Adjusted minutes were computed by 
dividing raw minutes by total wearing time and multi-
plying the resulting fraction by the average wearing time 
for all participants. We summarized the adjusted total 
daily amount of moderate-to-vigorous physical activity, 
light-intensity physical activity, and sedentary behavior 
in minutes for each participant at all 4 study time points.
Statistical Analysis
Descriptive statistics (means and percentages) were 
used to compare participants who did and did not pro-
vide valid objectively measured physical activity data at 
the Washington University site. Participants were com-
pared with respect to socio-demographic characteris-
tics, prostate cancer-related factors, and surgery-related 
factors. Medians and interquartile ranges were used 
to summarize participants’ self-reported moderate-to-
vigorous physical activity and objectively measured 
time spent in moderate-to-vigorous physical activity, 
light-intensity physical activity, and sedentary behav-
ior. Changes in activity over time were compared using 
Friedman’s test. Post hoc analyses using Wilcoxon’s 
signed-rank tests were performed to identify times 
when changes occurred. Finally, agreement between 
self-reported and objectively measured physical activity 
was evaluated using Spearman’s rank correlation coef-
ficient. Data analyses were conducted using STATA, 
SAS, and R.
RESULTS
In total, 350 participants completed the baseline sur-
vey before radical prostatectomy at the Washington 
University site, and 310 (88.6%) provided complete sur-
vey data at all 4 study time points. Of these men, 203 
agreed to wear an accelerometer, and 193 provided valid 
objectively measured physical activity data at baseline, 
143 at 5 weeks, 119 at 6 months, and 108 at 12 months, 
for a total of 81 men with complete objectively measured 
physical activity data at all 4 time points (Fig. 1). These 
81 participants were similar to those who did not provide 
valid objectively measured physical activity data, with the 
exception of race, body mass index, marital status, presur-
gical prostate-specific antigen concentration, and possibly 
education. Of the 26 (8.4% of 310) African American 
participants who completed the study, only 1 (1.2% of 
81) provided objectively measured physical activity data 
(Table 1). In addition, men who did not provide valid ob-
jectively measured physical activity data were more likely 
to be obese, live alone, and have a higher presurgical 
prostate-specific antigen concentration than participants 
who did provide valid objectively measured physical ac-
tivity data. They were also nonsignificantly less likely to 
have completed a graduate education. Overall, the ma-
jority of the 81 analyzed men were overweight (49.4%) 
or obese (35.8%), had completed a college education or 
more (50.3%), earned ≥$75,000 (52.6%), were married or 
living as married (82.6%), and had clinical stage T1 dis-
ease (76.8%), with a median presurgical prostate-specific 
antigen level of 5.2 ng/mL (interquartile range, 4.1-6.9).
Self-Reported Physical Activity
At baseline, participants’ self-reported levels of daily 
moderate-to-vigorous physical activity were high (median 
= 32.1 minutes), with 72.8% meeting general physical ac-
tivity guidelines (ie, 150 min/wk of moderate-to-vigorous 
physical activity) (Table 2). These levels declined 5 weeks 
after radical prostatectomy (15.0 minutes; post hoc P < 
.001 compared with baseline; 38.3% meeting physical 
activity guidelines), followed by a recovery at 6 months 
(32.1 minutes; post hoc P < .001 compared with 5 weeks 
after radical prostatectomy; 70.4% meeting physical ac-
tivity guidelines). Self-reported physical activity levels 
remained stable at 12 months (47.1 minutes; post hoc P 
= ..30 compared with 6 months post-RP; 71.6% meeting 
physical activity guidelines).
Objectively Measured Physical Activity
In contrast to self-reported moderate-to-vigorous physical 
activity, objective measures were low at all 4 time points 
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(median, 0.0-5.2 min/day; 6.2%-11.1% meeting physical 
activity guidelines) and showed no overall change across 
study assessments (global P = .29) (Table 2). However, 
stepwise comparisons indicated a statistically significant 
but small decline in objectively measured daily moderate-
to-vigorous physical activity from 5 weeks (5.2 minutes) 
to 6 months after radical prostatectomy (0.0 minutes; P 
= .03).
With regard to objectively measured light-intensity 
physical activity, a similar pattern of findings was ob-
served as for self-reported moderate-to-vigorous physical 
activity. Participants engaged in a median of 195.6 min-
utes of daily light-intensity physical activity before radical 
prostatectomy, after which they experienced a significant 
decline 5 weeks after radical prostatectomy (180.4 min-
utes; post hoc P < .001 compared with baseline). Levels of 
daily light-intensity physical activity recovered 6 months 
after radical prostatectomy (201.2 minutes; post hoc 
P = .01 compared with 5 weeks after radical prostatec-
tomy), and remained stable at 12 months (190.1 minutes; 
post hoc P = .61 compared with 6 months after radical 
prostatectomy).
Finally, the opposite pattern of findings was ob-
served for sedentary behavior as for light-intensity 
physical activity. Participants accumulated higher levels 
of sedentary behavior 5 weeks after radical prostatec-
tomy (median, 511.5 minutes) compared with base-
line (488.8 minutes; post hoc P = .001), after which 
their levels returned to baseline (6 months after radical 
prostatectomy: 489.3 minutes; post hoc P = .02 com-
pared with 5 weeks after radical prostatectomy; post 
hoc P = .84 compared with baseline; and 12 months 
after radical prostatectomy: 501.5 minutes; post hoc 
P = .87 compared with baseline).
Figure 1. Flow diagram illustrating prostate cancer survivors in the Prostatectomy, Incontinence, and Erectile Function Study 
(PIE) population and analyzed sample.
PIE overall enrollment
(n=426)
Agreed to wear an 
accelerometer
(n=203)
Washington University 
School of Medicine site 
enrollment
(n=350)
Provided complete survey 
data at four study time points 
(n=310)
Brigham & Women’s 
Hospital site enrollment
(n=76)
Provided valid 
accelerometer data at four 
study time points
(n=81)
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TABLE 1. Baseline Characteristics of Participants in the Prostatectomy, Incontinence, and Erectile Function 
Study
Sociodemographic Total (N = 310)
Provided Valid Objectively Measured Physical 
Activity Data
PNo (n = 229) Yes (n = 81)
Age, y, mean (SD) 61.1 (6.9) 60.8 (7.0) 61.9 (6.4) .27
Race, n (%) .02
White 283 (91.3) 203 (88.7) 80 (98.8)
African American 26 (8.4) 25 (10.9) 1 (1.2)
Asian 1 (0.3) 1 (0.4) 0 (0)
BMI, n (%) .005
Normal weight (18.5-24.9 kg/m2) 46 (14.8) 27 (11.8) 19 (23.5)
Overweight (25.0-29.9 kg/m2) 153 (49.4) 110 (48.0) 43 (53.1)
Obese (≥30 kg/m2) 111 (35.8) 92 (40.2) 19 (23.4)
Education, n (%) .12
High school degree or less 56 (18.1) 46 (20.1) 10 (12.3)
Some college 98 (31.6) 76 (33.2) 22 (27.2)
College degree 75 (24.2) 54 (23.6) 21 (25.9)
Postgraduate 81 (26.1) 53 (23.1) 28 (34.6)
Household income, n (%) .38
$50,000-<$75,000 147 (47.4) 112 (48.9) 35 (43.2)
≥$75,000 163 (52.6) 117 (51.1) 46 (56.8)
Marital status, n (%) .02
Married or living with partner 256 (82.6) 182 (79.5) 74 (91.4)
Living alone 54 (17.4) 47 (20.5) 7 (8.6)
Cigarette smoking status, n (%) .30
Never smoked 179 (57.8) 132 (57.7) 47 (59.3)
Former smoker 108 (34.8) 77 (33.6) 31 (34.2)
Current smoker 23 (7.4) 20 (8.7) 3 (5.5)
T1 stage before surgery, n (%) 238 (76.8) 173 (75.6) 65 (82.3) .39
PSA level before surgery, median 
(IQR)
5.2 (4.1-6.9) 5.4 (4.3-7.2) 4.6 (3.9-5.8) .04
Surgical procedure, n (%) .20
Laparoscopic 150 (48.4) 117 (51.1) 33 (40.7)
Open 18 (5.8) 14 (6.1) 4 (5.0)
Robotic 142 (45.8) 98 (42.8) 44 (54.3)
Abbreviations: BMI, body mass index; IQR, interquartile range; PSA, prostate-specific antigen; SD, standard deviation.
TABLE 2. Median and Interquartile Range of Activity Patterns Among Prostate Cancer Survivors in the 
Prostatectomy, Incontinence, and Erectile Function Study (n = 81)
Baseline 5 weeks 6 months 12 months P
Questionnaire (CHAMPS)
Moderate-to-vigorous intensity physical activity
Daily minutes 32.1 (15.0-77.1) 15.0 (0.0-32.1) 32.1 (15.0-64.3) 47.1 (15.0-79.3) <.001
Meeting physical activity guideline 72.8% 38.3% 70.4% 71.6%
Post hoc P <.001 <.001 .30
Accelerometer (Actigraph GTX 3)
Moderate-to-vigorous intensity physical activity
Daily minutes 3.9 (0.0-11.5) 5.2 (0.0-11.4) 0.0 (0.0-7.5) 3.1 (0.0-11.1) .29
Meeting physical activity guideline 11.1% 11.1% 8.6% 6.2%
Post hoc P .96 .03 .45
Light-intensity physical activity
Daily minutes 195.6 (159.7-240.6) 180.4 (141.1-214.3) 201.2 (161.5-244.9) 190.1 (165.9-243.6) .008
Post hoc P <.001 .01 .61
Sedentary behavior
Daily minutes 488.8 (448.8-529.3) 511.5 (467.3-554.8) 489.3 (445.7-525.3) 501.5 (439.2-529.1) .02
Post hoc P .001 .02 .58
Friedman’s test.
Community Healthy Activities Model Program for Seniors.
Wilcoxon’s signed-rank test to compare the change with the previous data point.
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Agreement Between Self-Reported and 
Objectively Measured Physical Activity
Agreement between self-reported and objectively meas-
ured moderate-to-vigorous physical activity was poor at 
all 4 time points (Ρ = 0.07-0.27) (Table 3), as expected 
based on their differing patterns of findings over study 
follow-up. In contrast, self-reported moderate-to-vigorous 
physical activity and objectively measured light-intensity 
physical activity were in considerably better agreement (Ρ 
= 0.29-0.42, P = .009-0.32 compared with self-reported 
and objectively measured moderate-to-vigorous physical 
activity agreement).
DISCUSSION
The findings from our prospective cohort study of 
prostate cancer survivors show a disagreement between 
self-reported and objectively measured levels of moder-
ate-to-vigorous physical activity both before and after 
surgery. Whereas self-reported moderate-to-vigorous 
physical activity levels were high and generally above 
physical activity guidelines at all study time points except 
for 5 weeks after radical prostatectomy, objectively meas-
ured levels were low and generally below physical activ-
ity guidelines at all 4 study time points. Interestingly, 
similar patterns of change were observed for self-reported 
moderate-to-vigorous physical activity as for objectively 
measured light-intensity physical activity and a stronger 
correlation was observed between self-reported moderate-
to-vigorous physical activity and objectively measured 
light-intensity physical activity than between self-re-
ported and objectively measured moderate-to-vigorous 
physical activity, suggesting that self-reported moderate-
to-vigorous physical activity may have been more likely 
to capture physical activity at light intensity than moder-
ate or vigorous intensities in this study population with 
critically low moderate-to-vigorous physical activity.
To the best of our knowledge, our study is the 
first to report trajectories of physical activity (either 
self-reported or objectively measured) in prostate cancer 
survivors, precluding a comparison to previous studies. 
However, our findings for individual physical activity 
measures and values are consistent with those from pre-
vious studies. For example, our observed decline shortly 
after surgery is consistent with findings from a study of 
Australian breast and prostate cancer survivors in which 
participants reported a decline in self-reported weekly 
moderate-to-vigorous physical activity of 72 minutes in 
the 6 weeks after diagnosis.12 In addition, our findings 
of generally low objectively measured moderate-to-vig-
orous physical activity at all time points after radical 
prostatectomy are consistent with those from a previ-
ous nationally representative cross-sectional sample of 
American prostate cancer survivors in various stages of 
their recovery that observed low levels of physical activ-
ity (6.0 minutes of moderate-to-vigorous physical activ-
ity, 4.0 hours of light-intensity physical activity, and 9.9 
hours of sedentary behavior) using the same cpm cutoffs 
for accelerometer data used in our study.30 These val-
ues are within 10 minutes of our values; therefore, it is 
likely that they are clinically similar.31 Therefore, given 
these similarities in findings for individual physical ac-
tivity measures, it is likely that our observed discrepancy 
between self-reported and objectively measured moder-
ate-to-vigorous physical activity (ie, overestimation of 
moderate-to-vigorous physical activity by self-report), 
and perhaps our better agreement between self-reported 
moderate-to-vigorous physical activity and objectively 
measured light-intensity physical activity, would also 
generalize to these study populations.
Self-reported measures may overestimate objectively 
measured moderate-to-vigorous physical activity for sev-
eral reasons. The first is the nature of the questionnaire 
design. For example, the CHAMPS questionnaire in-
cludes a few sets of different items that may in fact cap-
ture the same activity (for example, walking fast, walking 
leisurely, walking for errands, and walking uphill), which 
TABLE 3. Agreement (ρ) of Self-Reported Moderate-to-Vigorous Physical Activity With Accelerometer-
Measured Moderate-to-Vigorous Physical Activity and Light-Intensity Physical Activity, Respectively, in 
Prostate Cancer Survivors in the Prostatectomy Incontinence and Erectile Function Study (n = 81)
Self-reported moderate-to-vigorous 
physical activity
Accelerometer Measured (min/day)
Moderate-to-Vigorous Physical Activity Light-Intensity Physical Activity
Baseline 0.22 0.29
5 wk after radical prostatectomy 0.27 0.39
6 mo after radical prostatectomy 0.07 0.42
12 mo after radical prostatectomy 0.16 0.35
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may lead to double counting and overestimation of phys-
ical activity. This concern is particularly problematic for 
common activities, such as walking (prevalence in our 
sample: walking fast, 32%-42%; walking leisurely, 51%-
69%; walking for errands, 44%-48%; and walking uphill, 
30%-33%). It has also been found to be more common 
in men than in women.32 Another reason self-reported 
moderate-to-vigorous physical activity may overestimate 
actual values, particularly in cancer survivors, is response 
bias.33 Unlike the general population, cancer survivors 
experience major changes in aerobic capacity, body 
composition, and mental burden from their cancer and 
its treatment, which may influence their perceptions of 
physical activity intensity dramatically. For example, we 
speculate that men who suffer from radical prostatecto-
my-related adverse effects may perceive the same activity 
that was “light” before radical prostatectomy (eg, “work 
on your car, truck, lawn mower, or other machinery”) 
as “heavy” after radical prostatectomy. Finally, it is also 
possible that men may report a longer duration of activity 
because of their strong desire to be active, an important 
component of perceived normalcy for men after prostate 
cancer treatment.34
Considering our findings in light of cancer survivor 
physical activity guidelines (ie, 150 minutes of weekly 
moderate-to-vigorous physical activity35), our results for 
self-reported data tend to meet these guidelines, but those 
for objectively measured moderate-to-vigorous physical 
activity fall far short. However, because previous physical 
activity recommendations for prostate cancer survivors 
were derived from self-reported data,36 which appears to 
overestimate actual moderate-to-vigorous physical activ-
ity and may instead capture light-intensity activity, it is 
possible that clinically relevant health benefits could still 
be accrued at intensities and durations of physical activity 
below currently recommended levels.37 This conclusion, 
which is in line with a growing body of research on the 
benefits of light-intensity physical activity,38,39 would be 
helpful for prostate cancer survivors for several reasons. 
First, large amounts of moderate-to-vigorous physical 
activity may be difficult for prostate cancer survivors to 
achieve, particularly those who engage in low levels of 
moderate-to-vigorous physical activity before surgery (ie, 
the large majority of our cohort). This unrealistic increase 
in moderate-to-vigorous physical activity may partially ex-
plain the low adherence rates seen in many previous phys-
ical activity interventions.40 Second, increases in physical 
activity at light intensity rather than moderate or vigorous 
intensities may be more achievable because of their lesser 
physiological stress and ease of performance even in the 
presence of adverse effects. This hypothesis is supported 
by our observation of a recovery in light-intensity physical 
activity for prostate cancer survivors between 5 weeks and 
6 months after radical prostatectomy. Thus, given these 
potential benefits, both in terms of “achievability” and 
health, additional research is warranted examining the 
influence of light-intensity physical activity on prostate 
cancer survival, particularly using measurement tools ca-
pable of capturing physical activities of various intensi-
ties accurately. Additionally, an in-depth understanding 
of the biological consequences of these activities—and 
perhaps more importantly the biological consequences of 
the energy expenditure associated with these activities—
according to disease factors and personal characteristics 
is required. Such knowledge is critical to design effective 
physical activity interventions that are achievable in wider 
cancer survivor populations unlikely to engage in moder-
ate-to-vigorous physical activity.
Our study population consisted of prostate cancer 
survivors with relatively high educational attainment and 
socioeconomic status who were treated for early-stage 
prostate cancer by minimally invasive radical prosta-
tectomy procedures. Therefore, our observed degree of 
discrepancy between self-reported and objectively mea-
sured physical activity and our observed absolute physi-
cal activity levels may not generalize to men with lesser 
educational attainment or socioeconomic status or men 
treated for later-stage prostate cancer or by open or dif-
ferent therapeutic procedures with a greater impact on 
physical and mental function. In fact, it is likely that a 
higher degree of discrepancy and lesser absolute physical 
activity levels would have been observed in these men. 
Nonetheless, we believe our overall conclusion of a pos-
sible benefit of light-intensity physical activity might also 
apply to these men, because they are even less likely to 
engage in high levels of moderate-to-vigorous physical ac-
tivity. In addition, although our study population differs 
from the general population of prostate cancer survivors, 
it is similar to study populations in which the influence of 
physical activity on prostate cancer survival has been stud-
ied,3,4,41,42 possibly making our findings more relevant 
to the interpretation of these previous studies. Finally, 
given the potential implications of our findings (ie, that 
light-intensity physical activity may still be beneficial for 
cancer survival), researchers should explore the possible 
benefit of this intensity of physical activity for survivors 
of other cancers in older men, as well as those that affect 
women and younger individuals.
There are a number of strengths to this study. 
These include its prospective study design, collection of 
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objectively measured physical activity data, moderate to 
high follow-up rate for accelerometer measures (5 weeks 
= 74.1%, 6 months = 61.7%, 12 months = 56.0%), and 
large sample size. In fact, our study is the largest study 
to date to collect repeated objective measures of physical 
activity before and after treatment.
Our study also has some limitations. Lower limb 
movements (such as cycling) or strength training ac-
tivities may be underestimated by hip-worn acceler-
ometers, resulting in underestimated levels of objective 
physical activity. Although these types of activities are 
not expected to be prevalent in men 5 weeks after sur-
gery, they may have been more common once partici-
pants recovered from their surgery at 6 and 12 months 
follow-up. Discrepancies between self-reported and 
objective measures of physical activity may have also 
been introduced by the possibly differing time frames 
of assessment of the CHAMPS questionnaire (activities 
in “a typical week during the past 4 weeks,” which par-
ticipants may have interpreted as the most recent week) 
and accelerometers (activity over a 7-day period near in 
time to questionnaire completion). This concern may 
be especially problematic for the 5-week assessment 
when participants’ activity levels likely varied markedly 
from week to week as they recovered from their sur-
gery. Nevertheless, our observed higher agreement at 
this time point suggests this may have been less of a 
concern, possibly because of participants’ overall low 
physical activity levels 5 weeks after surgery. Finally, 
although the magnitude of our findings may not gener-
alize to populations with different demographic or clin-
ical characteristics as our study population, we believe 
the inferences of our findings have broader generaliz-
ability, as described earlier.
In conclusion, in this prospective study of prostate 
cancer survivors, objectively measured moderate-to-vig-
orous physical activity levels were critically low from base-
line before to 12 months after radical prostatectomy. In 
contrast, self-reported levels were considerably higher and 
above the physical activity guidelines at all 4 time points 
for a large proportion of men, potentially reflecting 
light-intensity rather than moderate-to-vigorous physical 
activity levels. Because physical activity guidelines were 
derived from self-reported moderate-to-vigorous physi-
cal activity, it is possible that these guidelines may be too 
high for many men and that lower intensities of physical 
activity may still be beneficial. Therefore, additional re-
search into the potential benefits of physical activity at 
light intensity is warranted. Such research could lead to 
interventions that are achievable in a wider survivor pop-
ulation challenged to engage in physical activity at mod-
erate or vigorous intensities.
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